| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC2387 |
| Trial ID | NCT04438083 |
| Disease | Renal Cell Carcinoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CTX130 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC) |
| Year | 2020 |
| Country | Netherlands |
| Company sponsor | CRISPR Therapeutics AG |
| Other ID(s) | CRSP-ONC-003 |
| Cohort 1 | |||||||||
|
|||||||||